567 related articles for article (PubMed ID: 32094257)
1. Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.
Mangalea MR; Duerkop BA
Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32094257
[TBL] [Abstract][Full Text] [Related]
2. The Diverse Impacts of Phage Morons on Bacterial Fitness and Virulence.
Taylor VL; Fitzpatrick AD; Islam Z; Maxwell KL
Adv Virus Res; 2019; 103():1-31. PubMed ID: 30635074
[TBL] [Abstract][Full Text] [Related]
3. Combatting intracellular pathogens using bacteriophage delivery.
Goswami A; Sharma PR; Agarwal R
Crit Rev Microbiol; 2021 Aug; 47(4):461-478. PubMed ID: 33818246
[TBL] [Abstract][Full Text] [Related]
4. The disparate effects of bacteriophages on antibiotic-resistant bacteria.
Torres-Barceló C
Emerg Microbes Infect; 2018 Oct; 7(1):168. PubMed ID: 30302018
[TBL] [Abstract][Full Text] [Related]
5. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
Luong T; Salabarria AC; Roach DR
Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
[TBL] [Abstract][Full Text] [Related]
6. Beyond antibacterials - exploring bacteriophages as antivirulence agents.
Shen Y; Loessner MJ
Curr Opin Biotechnol; 2021 Apr; 68():166-173. PubMed ID: 33333352
[TBL] [Abstract][Full Text] [Related]
7. Phage therapy for respiratory infections.
Chang RYK; Wallin M; Lin Y; Leung SSY; Wang H; Morales S; Chan HK
Adv Drug Deliv Rev; 2018 Aug; 133():76-86. PubMed ID: 30096336
[TBL] [Abstract][Full Text] [Related]
8. Use of bacteriophage to target bacterial surface structures required for virulence: a systematic search for antibiotic alternatives.
Orndorff PE
Curr Genet; 2016 Nov; 62(4):753-757. PubMed ID: 27113766
[TBL] [Abstract][Full Text] [Related]
9. Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy.
Oechslin F
Viruses; 2018 Jun; 10(7):. PubMed ID: 29966329
[TBL] [Abstract][Full Text] [Related]
10. Phages amid antimicrobial resistance.
Mohan Raj JR; Karunasagar I
Crit Rev Microbiol; 2019; 45(5-6):701-711. PubMed ID: 31775552
[TBL] [Abstract][Full Text] [Related]
11. Ameliorating the antimicrobial resistance crisis: phage therapy.
Saha D; Mukherjee R
IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
[TBL] [Abstract][Full Text] [Related]
12. Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy.
Fujiki J; Nakamura K; Nakamura T; Iwano H
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958612
[TBL] [Abstract][Full Text] [Related]
13. Fitness Trade-Offs in Phage Cocktail-Resistant Salmonella enterica Serovar Enteritidis Results in Increased Antibiotic Susceptibility and Reduced Virulence.
Gao D; Ji H; Wang L; Li X; Hu D; Zhao J; Wang S; Tao P; Li X; Qian P
Microbiol Spectr; 2022 Oct; 10(5):e0291422. PubMed ID: 36165776
[TBL] [Abstract][Full Text] [Related]
14. Back to the future: bacteriophages as promising therapeutic tools.
Domingo-Calap P; Georgel P; Bahram S
HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
[TBL] [Abstract][Full Text] [Related]
15. Virulence-associated factors as targets for phage infection.
de Melo AG; Morency C; Moineau S
Curr Opin Microbiol; 2024 Jun; 79():102471. PubMed ID: 38569419
[TBL] [Abstract][Full Text] [Related]
16. A simple solid media assay for detection of synergy between bacteriophages and antibiotics.
Khong E; Oh JJ; Jimenez JM; Liu R; Dunham S; Monsibais A; Rhoads A; Ghatbale P; Garcia A; Cobián Güemes AG; Blanc AN; Chiu M; Kuo P; Proost M; Kline A; Aslam S; Schooley RT; Whiteson K; Fraley SI; Pride DT
Microbiol Spectr; 2024 May; 12(5):e0322123. PubMed ID: 38526142
[TBL] [Abstract][Full Text] [Related]
17. Framing the Future with Bacteriophages in Agriculture.
Svircev A; Roach D; Castle A
Viruses; 2018 Apr; 10(5):. PubMed ID: 29693561
[TBL] [Abstract][Full Text] [Related]
18. Deploying Viruses against Phytobacteria: Potential Use of Phage Cocktails as a Multifaceted Approach to Combat Resistant Bacterial Plant Pathogens.
Farooq T; Hussain MD; Shakeel MT; Tariqjaveed M; Aslam MN; Naqvi SAH; Amjad R; Tang Y; She X; He Z
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215763
[TBL] [Abstract][Full Text] [Related]
19. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy.
Segall AM; Roach DR; Strathdee SA
Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502
[TBL] [Abstract][Full Text] [Related]
20. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
